|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Pharma's Image Fix: Lessons from the Fieldover 7 years ago
The Innovation Distinction: Biopharma's Reputational Passover 7 years ago
Valeant’s Northern Faceover 7 years ago
More New Drugs and Generics Reshape Pharma Marketsover 7 years ago
Leadership in All the Right Placesover 7 years ago
Industry Engine CheckNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Merck Planning $70 Billion Investment for US Expansion
2
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
